YARROW BIOSCIENCE, INC. Deferred Tax Liabilities, Gross
YARROW BIOSCIENCE, INC. (YARW) had Deferred Tax Liabilities, Gross of $0 as of 2023-12-31, per its 10-K filed 2024-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2024-03-01
- 2023-12-31: Deferred Tax Liabilities, Gross $0.00.
- 2022-12-31: Deferred Tax Liabilities, Gross $0.00.
- 2021-12-31: Deferred Tax Liabilities, Gross $116.00K.
- 2020-12-31: Deferred Tax Liabilities, Gross $386.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-01 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 |
| 2021-12-31 | $116.00K 10-K · filed 2023-03-14 |
| 2020-12-31 | $386.00K 10-K · filed 2022-03-17 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |